Precious Metals

Sydney, Australia (ABN Newswire) - Beroni Group (OTCMKTS:BNIGF) (NSX:BTG), an Australia-based diversified biopharmaceutical enterprise today announced that it has signed a Memorandum of Understanding with tella, Inc. to collaborate in the field of immunotherapy for cancer treatment.
tella is a Japanese company contributing to the advancement of cancer therapy through the research and development of cancer vaccines. tella's dendritic cell vaccine therapy aims to increase the dendritic cell population and strengthen the attacking system against cancers. In 2019, tella's dendritic cell vaccine therapy has been provided to approximately 12,200 patients in 28 medical institutions around Japan.

Beroni and tella acknowledge that the resources possessed by each party and their respective affiliates such as technologies, knowledge and networks, are of high value to each other. In this context, they intend to build strategic partnerships in the field of immunotherapy for cancer treatment, such as conducting clinical trials in dendritic cell vaccine and gamma delta T cells in both Japan and China, crossing shareholding by both parties, technical exchange between both parties and other strategic developments.

"Dendritic cell vaccine therapy has been studied around the world as an advanced 'state-of-the-art cancer immune cell therapy' that ensures more reliable action on fighting cancer cells by employing the patient's own immune cells, than other cancer vaccines. It is also expected to be effective for prevention or recurrence after standard treatment." said Tomoyuki Taira, President of tella, Inc. "We look forward to a long- term and cooperative working relationship with Beroni. This collaboration can help us provide dendritic cell vaccine therapy to more people in more geographical locations and more cancer patients can thus be cured."

"This is a significant milestone in advancing our clinical trials in cancer treatment. With this partnership, we can conduct clinical trials together with tella in Japan. With our multicenter clinical studies, we can include a larger number of participants in diverse geographical locations and can compare results among centers, thereby increasing the generalizability of our study results." commented Jacky Zhang, Chairman and CEO of Beroni Group. "We are excited to work with tella in developing new cell therapies using their advanced dendritic cell vaccine therapy. We also look forward to developing our new cellular immunotherapy based on gamma delta T cells with tella in Japan. "

About tella, Inc

tella, Inc is a Japanese company listed on the Tokyo Stock Exchange (TYO:2191) providing technical and operational knowhow associated with cell medicines, including dendritic cell vaccine therapy, to affiliated medical institutions. It also conducts clinical research of new regenerative medicine and cell medicine such as immunotherapy, cell processing devices and pharmaceutical products involving the use of dendritic cell vaccine therapy.



About Beroni Group Limited:

Beroni Group (NSX:BTG) (OTCMKTS:BNIGF) is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. Its diversified portfolio is comprised of a US FDA approved virus diagnostic kit, an e-commerce platform for the sale of pharmaceutical products and a development pipeline targeting oncology and cell therapies. Beroni has operations in Australia, United States, China and Japan. To learn more about Beroni, please visit www.beronigroup.com.



Source:
Beroni Group Limited



Contact:
Dragon Gate Investment Partners LLC
Tel: +1(646)-801-2803
Email: BNIGF@dgipl.com

News Provided by ABN Newswire via QuoteMedia

silver and gold coins

5 Top Weekly TSX Performers: Wallbridge Mining Rises on Fenelon Assay Results

The S&P/TSX Composite Index (INDEXTSI:OSPTX) was trading at 19,501.18 early last Friday (August 5) morning. It ultimately closed the week higher at 19.619.88.

Looking over to commodities prices, gold rose as recession fears pushed investors toward safe-haven assets. The yellow metal was hovering around the US$1,775 per ounce mark, while its sister metal silver was trading at US$19.80 per ounce on the week's last day of trading.

That said, all eyes were on platinum and palladium last week as analysts and traders lowered their price forecasts for the year on sluggish demand from the auto sector, a Reuters poll shows.

Keep reading...Show less
Impact Minerals

Impact to Sell a 75% Interest in the Commonwealth Project, New South Wales

Impact Minerals Limited (ASX:IPT) is pleased to announce that it has agreed terms for the sale of a 75% interest in its 100% owned Commonwealth Project in the Lachlan copper-gold province of New South Wales (Figure 1).

Keep reading...Show less
us money with stock chart

Top Stories This Week: Gold Price Bounces Back, Experts Talk Recession Question

Weekly August 5youtu.be

After dipping briefly below the US$1,700 per ounce mark in mid-July, gold is bouncing back.

The yellow metal has made a big move since last week's US Federal Reserve meeting, nearly making it to US$1,800. It was back down around US$1,775 at the time of this writing on Friday (August 5) afternoon.

The Fed hiked interest rates last week by 75 basis points, as was widely expected by market participants. Major indexes have been on the rise, which Lobo Tiggre of IndependentSpeculator.com told me is unsurprising.

Keep reading...Show less
hand holding gold bar

VIDEO — Rick Rule: Glad to See Gold on Sale, "Solidly Bullish" on Uranium

Rick Rule Symposium 2022youtu.be

Gold has seen ups and downs this summer, but is solidly below its Q1 peak of over US$2,000 per ounce.

Speaking to the Investing News Network at the Rule Symposium in Florida, Rick Rule, the host of the event and proprietor at Rule Investment Media, said he sees the lack of interest in the yellow metal as positive.

"The fact that people are disinterested in gold, and disinterested in resources, I think is a wonderful thing because they're on sale," he explained, reminding listeners that he favors a contrarian approach to the markets.

Keep reading...Show less
front entrance to the Boca Raton resort

Rule Symposium 2022: Fed Can’t Fight Inflation and Recession at Same Time

The last week of July saw market experts, investors and company executives descend on Boca Raton, Florida, for the Rule Symposium, hosted by veteran investor and speculator Rick Rule.

The four day event, which ran from July 26 to 29, featured numerous panels, presentations and discussions about the current commodities cycle and what is driving the equity markets.

There was also rigorous discourse regarding the mode, drivers and factors causing inflation, as well as how central banks like the US Federal Reserve are responding with interest rate increases.

Keep reading...Show less
jim cramer

Is Gold a Buy? Jim Cramer Says Timing Looks "Perfect"

As volatility reigns supreme across equity markets, many analysts are saying that gold’s fall below US$1,800 per ounce means it’s a good time to buy before the price goes up.

Gold's dip under that threshold began at the beginning of July, and is the first time the yellow metal has slipped below and held at that level since late 2021. The decline comes after gold breached US$2,000 in early March.

Many market participants remain resolute that it’s only a matter of time before gold regains its lost momentum, and that sentiment was echoed on Wednesday (August 3) by well-known TV personality Jim Cramer during the "Off the Charts" segment of his “Mad Money” investing show on CNBC.

Keep reading...Show less

Latest Press Releases

Related News

×